共 71 条
[1]
Devlin NJ(2017)EQ-5D and the ZuroQol group: past, present and future Appl. Health Econ. Health Policy 15 127-137
[2]
Brooks R(2021)Mapping EQ-5D-3L to EQ-5D-5L Value Health 24 1285-1293
[3]
van Hout BA(2018)Time trade-off value set for EQ-5D-3L based on a nationally representative chinese population survey Value Health 21 1330-1337
[4]
Shaw JW(2021)Valuation of the EQ-5D-3L in Russia Qual. Life Res. 30 1997-2007
[5]
Zhuo L(2020)Multiplicative modelling of EQ-5D-3L TTO and VAS values Eur. J. Health Econ. 21 1411-1420
[6]
Omelyanovskiy V(2018)Is EQ-5D-5L better than EQ-5D-3L? A head-to-head comparison of descriptive systems and value sets from seven countries Pharmacoeconomics 36 675-697
[7]
Shafie AA(2021)Comparing the measurement properties of the EQ-5D-5L and the EQ-5D-3L in hypertensive patients living in rural China Qual Life Res. 30 2045-2060
[8]
Vasan Thakumar A(2021)Comparison of the three-level and the five-level versions of the EQ-5D Eur. J. Health Econ. 22 621-628
[9]
Janssen MF(2021)US population norms for the EQ-5D-5L and comparison of norms from face-to-face and online samples Qual. Life Res. 30 803-816
[10]
Bonsel GJ(2020)EQ-5D-5L Slovenian population norms Health Qual. Life Outcomes. 18 333-1318